Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Understanding impulsivity in Parkinson's patients with deep brain stimulation

Official title: Frontosubthalamic Network Dynamics and Their Modulation During Impulse Control and Decision Making in Parkinson's Disease

Run by University of Oxford · NCT06485986 · Data updated 2026-11-12

This study is testing how deep brain stimulation affects impulsivity in people with Parkinson's disease to see if different settings can help reduce impulsive behavior.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment20 (estimated)
SponsorUniversity of Oxford
Academic / other
Locations1 site (Oxford)
StatusRecruiting
StartedJune 1, 2024
Main results expectedAugust 1, 2026
Study endsAugust 31, 2026
Registry record updatedApril 2, 2025
Trial IDNCT06485986 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates include adults aged 18 and older diagnosed with Parkinson's disease who have undergone DBS and may or may not have impulse control disorders.

Probably not a fit

Patients with extreme language barriers, other neurological disorders, or those enrolled in conflicting clinical studies may not benefit from this research.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This experimental study aims to investigate the mechanisms behind increased impulsivity in some Parkinson's disease patients who undergo deep brain stimulation (DBS) of the subthalamic nucleus. Participants will engage in decision-making tasks while their DBS devices are toggled on and off, allowing researchers to observe the effects on brain activity through magnetoencephalography (MEG). The study seeks to identify the network effects of DBS and explore alternative stimulation settings that may reduce impulsivity. By analyzing these interactions, the research hopes to provide insights into optimizing DBS for better patient outcomes.

Why it matters

Potential benefit: If successful, this study could lead to improved DBS settings that minimize impulsivity in Parkinson's disease patients.

How similar studies have gone: While there have been studies on DBS in Parkinson's disease, this specific focus on impulsivity and network effects is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participant is willing and able to give informed consent for participation in the study.
* Male or Female, aged 18 years or above.
* Diagnosed with Parkinson's disease who have required implanted STN electrodes for DBS in addition to their dopamine replacement therapy.
* Diagnosed with or without (control group) impulse control disorders since the diagnosis of Parkinson's Disease.
* Participant willing and able to sit in the MEG scanner and follow instructions.
* Participant willing and able to delay their morning dose of dopamine replacement therapy for up to four hours (180 minutes experimental time + journey time).

Exclusion Criteria:

* Patients with extreme language barrier that cannot understand the purpose or instructions of the study despite the use of an interpreter.
* Other implanted medical devices that may cause artefacts during MEG recordings.
* Participants with a history of co-morbid neurological disorders.
* Participant enrolled onto another clinical trial related to a neurological disorder (including Parkinson's disease) that may interfere with the results of this study.
* Participants who are unable to sit still in a MEG scanner for the duration of this experiment e.g. patients with chronic pain or osteoarthritis. This will be assessed with their primary clinician

Where it's running

  • John Radcliffe Hospital
    Oxford, United Kingdom
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.